Search
for
Sort by
Research 151–180 of 918
- Prevalence of hepatic steatosis in women with polycystic ovary syndrome
- Granzyme B in Autoimmune Skin Disease
- Polycystic Ovarian Syndrome: Long-Term Health Consequences
- Comparison of prevalence of periodontal disease in women with polycystic ovary syndrome and healthy controls
- Androgen excess and post-reproductive health
- A Comprehensive Approach in Diagnosing the Polycystic Ovary Syndrome
- Serum C-19 steroid sulphates in females with clinical hyperandrogenism
- Correlation of cutaneous manifestations with body mass index, blood glucose, and hormonal levels in patients with polycystic ovarian disease
- Role of plasminogen activator inhibitor type 1 (PAI-1) in PCOS patient
- P-017 CUSHING'S SYNDROME DUE TO PRIMARY BILATERAL MACRONODULAR ADRENAL HYPERPLASIA AND METACRONOUS PHEOCHROMOCYTOMA
- Hyperandrogenism and Cardiometabolic Risk in Pre- and Postmenopausal Women—What Is the Evidence?
- Metabolic Aspects of Polycystic Ovary Syndrome
- Workup and Management of Polycystic Ovary Syndrome
- Langzeitwirkung von Trilostan bei Hunden mit Cushing-Syndrom
- Early Androgenetic Alopecia as a Predictor of Ischemic Heart Disease
- Hormonal Therapy for Acne
- Advances in Cell-Mediated Drug Delivery for Dermatologic Diseases: Mechanisms and Current Applications
- The Skin and Subcutaneous Tissues
- Cutaneous Manifestations of Endocrine Diseases
- Abdominal Obesity as a Predictive Factor of Nonalcoholic Fatty Liver Disease Assessed by Ultrasonography and Transient Elastography in Polycystic Ovary Syndrome and Healthy Women
- Alopecia Areata: Burden of Disease, Approach to Treatment, and Current Unmet Needs
- 8273 ACTH-Dependent Cushing's Syndrome due to Metastatic Cervical Cancer: A Case Report
- Drug Repositioning: New Approaches and Future Prospects for Life-Debilitating Diseases and the COVID-19 Pandemic Outbreak
- COVID-19 and endocrine and metabolic diseases. An updated statement from the European Society of Endocrinology
- The Safety and Efficacy of Tofacitinib in 24 Cases of Pediatric Rheumatic Diseases: Single Centre Experience
- Beyond the Follicle: A Narrative Review on How Systemic Diseases and Drugs Affect Alopecia
- Non‐biologic immunosuppressive drugs for inflammatory and autoimmune skin diseases
- Construction of the coexpression network involved in the pathogenesis of thyroid eye disease via bioinformatics analysis
- Skin Sceneries of Thyroid Disorders and Impact of Thyroid on Different Skin Diseases: A Scoping Review Focused on Pediatric Patients
- Comparative analysis of therapeutic outcomes in pediatric versus adult ophiasis-pattern alopecia areata: A review of treatment modalities and disease course